Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130617) titled 'Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Condition:
Efficacy
Safety
Megestrol Acetate
Adult Subject
Intervention:
Drug: Low dose of Megestrol Acetate Oral Suspension combined with standard therapy
Drug: Medium dose of Megestrol Ace...